Prostate Cancer UK’s Quality Checklist

Scottish Parliament. MSPs show their support for Prostate Cancer UK.Dunfermline MSP Bill Walker has pledged to support the swift implementation of a Prostate Cancer UK initiative in Fife.

As a long-time supporter of the charity, the MSP backed its Quality Checklist at a recent campaigning event in the Scottish Parliament. This best practise Checklist aims to stamp out inequalities in the provision of care. It sets out 15 national standards for care and support that Scottish men with prostate cancer should expect and demand, from the point of their diagnosis onwards.

Mr Walker said: “I am delighted to endorse Prostate Cancer UK’s Quality checklist and will be writing to NHS Fife to ask that it be adopted as soon as possible. It is essential that all men diagnosed with prostate cancer, the most common cancer among men in Scotland, get the support they need.”

Dr Sarah Cant, Director of Policy and Campaigns at Prostate Cancer UK, said: “There are over 19,000 Scottish men living with prostate cancer, many of whom have to make difficult treatment choices or cope with tough side effects. It is vital that every man with prostate cancer has access to the world class information, care and support he needs and deserves if we are to help men have a better quality of life in the future.

“We are delighted that Bill Walker MSP has shown his support for men with prostate cancer by endorsing our Quality Checklist, and urgently call on health professionals and Health Boards to follow their lead. Men with prostate cancer deserve the best, and we’re absolutely determined that’s exactly what they are going to get.”

The charity is working closely with men and their families, healthcare providers, politicians and health professionals to ensure that the checklist is adopted and implemented throughout Scotland.

To view the Quality Checklist please visit www.prostatecanceruk.org/qualitycare.

Scottish Parliament. MSPs show their support for Prostate Cancer UK.

Bill Walker MSP and Owen Sharp CEO of Prostate Cancer UK

Comments are closed.